NCT03948919View on ClinicalTrials.gov

Fecal Transplant for Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

November 3, 2023

Study Completion Date

January 4, 2024

Conditions
Ulcerative Colitis
Interventions
DRUG

Fecal microbiota

Lyophilized encapsulated fecal microbiota given daily for 8 weeks.

DRUG

Placebo

Placebo capsules identical in appearance to fecal microbiota capsules to be taken daily for 8 weeks.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03948919 - Fecal Transplant for Ulcerative Colitis | Biotech Hunter | Biotech Hunter